"Emollients" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Oleagenous substances used topically to soothe, soften or protect skin or mucous membranes. They are used also as vehicles for other dermatologic agents.
| Descriptor ID |
D004643
|
| MeSH Number(s) |
D27.505.954.444.200
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Emollients".
Below are MeSH descriptors whose meaning is more specific than "Emollients".
This graph shows the total number of publications written about "Emollients" by people in this website by year, and whether "Emollients" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Emollients" by people in Profiles.
-
Lo KBU, Azmaiparashvili Z. Desquamating pustular rash. Cleve Clin J Med. 2019 12; 86(12):780-781.
-
Ross NA, Chung HJ, Li Q, Andrews JP, Keller MS, Uitto J. Epidemiologic, Clinicopathologic, Diagnostic, and Management Challenges of Pityriasis Rubra Pilaris: A Case Series of 100 Patients. JAMA Dermatol. 2016 06 01; 152(6):670-5.
-
Wolf R, Parish LC. Barrier-repair prescription moisturizers: do we really need them? Facts and controversies. Clin Dermatol. 2013 Nov-Dec; 31(6):787-91.
-
Holdridge A, DiGregorio H, Selekman J. Breaking the silence: addressing skin issues in obese and overweight children. J Pediatr Nurs. 2013 Nov-Dec; 28(6):e22-7.
-
Tammaro A, Narcisi A, Persechino S, Caperchi C, Gaspari A. Topical and systemic therapies for nickel allergy. Dermatitis. 2011 Sep-Oct; 22(5):251-5.
-
Lacouture ME, Mitchell EP, Piperdi B, Pillai MV, Shearer H, Iannotti N, Xu F, Yassine M. Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer. J Clin Oncol. 2010 Mar 10; 28(8):1351-7.
-
Marionnet C, Bernerd F, Dumas A, Verrecchia F, Mollier K, Compan D, Bernard B, Lahfa M, Leclaire J, Medaisko C, Mehul B, Seit? S, Mauviel A, Dubertret L. Modulation of gene expression induced in human epidermis by environmental stress in vivo. J Invest Dermatol. 2003 Dec; 121(6):1447-58.